Telphone : +1 (905) 787-2041
Email Address: [email protected]

iHealth Solutions - Moving Forward

Moving Forward

Home
About Us
Our Services
News
Careers
Contacts

Author Archives: John Br.

iHealth Solutions > Articles by: John Br.

Search for:

Categories

BAXTER 1
BAYER 1
bioNtech 1
Boehringer 1
Disc Medicine 1
Eli Lilly 1
EMA 1
EMA 1
European Commission 1
FDA 1
Forensic science 1
Investment 1
Medtronic Symplicity 1
MERCK 1
NHS 1
Novo Nordisk 2
Oncology 2
Orbia 1
Ozempic 1
Sanofi 2
Scientific 2
TEVA 1
Uncategorized 1
virus therapy 1

Recent Posts

AstraZeneca and Merck’s Koselugo delivers phase 3 trial win in adults with NF1, teeing up filings14 November 2024
After Lilly’s GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy7 November 2024
Allurion boasts over 17% weight loss with swallowable balloon device5 November 2024
BioNTech reports surprising COVID vaccine sales in Q3 but tempers expectations for annual sales4 November 2024
Sanofi in ‘exclusive negotiations’ to sell 50% stake in €16B consumer health unit Opella21 October 2024

Tags

Allurion Technology ASTRAZENCA Bayer BioNtech biosimilar Boast Boehringer Chemistry COVID Disc Medicine Dry Eye EC Eli Lilly EMA equipment‎ EU APPROVAL fda HAIR LOSS healthcare investment Medical Medtronic Symplicity MENOPAUSE MERCK NF1 NHS Novo Nordisk Oncology Opella Ozempic Physics RMI Sanofi Théa Vaccine Wegovy WHO

Archives

November 2024
October 2024
September 2024
August 2024
July 2024
February 2023
January 2023

We are dedicated to providing reliable and
efficient distribution services to pharmacies,
hospitals, clinics, and healthcare
facilities across the country.

USEFUL LINKS

About Us
Our Services
Contacts
Blog & News
Client Portal

OUR SERVICES

API For Manufacturing
Regulatory Compliance
Product Sourcing
Manufacturing Materials
Medical Devices

RECENT POST

AstraZeneca and Merck’s Koselugo delivers phase 3 trial win in adults with NF1, teeing up filings 14 November 2024
After Lilly’s GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy 7 November 2024

Copyright © 2024 iHealth Solution Ltd. All rights reserved.